Commentary: Immune cell infiltration in aortic stenosis: Cause or consequence?
暂无分享,去创建一个
[1] K. Shirabe,et al. Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis , 2020, JTCVS open.
[2] P. D. del Nido,et al. Congenital aortic and truncal valve reconstruction using the Ozaki technique: Short-term clinical results. , 2020, The Journal of thoracic and cardiovascular surgery.
[3] B. Sepesi,et al. Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time? , 2020, The Journal of thoracic and cardiovascular surgery.
[4] T. D’amico,et al. The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons. , 2019, The Journal of thoracic and cardiovascular surgery.
[5] I. Konstantinov,et al. Commentary: Aortic valve calcification: A new story with a twist? , 2019, The Journal of thoracic and cardiovascular surgery.
[6] J. Marek,et al. The utility of aortic valve leaflet reconstruction techniques in children and young adults. , 2019, The Journal of thoracic and cardiovascular surgery.
[7] Hiromasa Yamashita,et al. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde‐treated autologous pericardium , 2018, The Journal of thoracic and cardiovascular surgery.
[8] Y. D'udekem. Aortic valve surgery in children , 2011, Heart.
[9] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.